RESUMO
The authors have studied age, microsocial, cultural, and psychopathological pathomorphosis in two groups of females (154 cases in total) with hysterical neurosis who were admitted to hospital in the early 1950s and early 1980s. The investigation has demonstrated that both the ratio of the main psychopathological disturbances in the structure of hysterical neurosis and their nature and severity have undergone definite changes. Vivid motor disorders rather prevalent in the 1950s have been shifted to the background by vegeto-somatic disturbances. At the same time sensory stigmas, while remaining fairly typical and frequent in the clinical course of hysterical neurosis, are becoming to be distinguished by increasingly unremarkable and elementary features, resembling the sensations reported by patients with somatic diseases.
Assuntos
Histeria/classificação , Transtornos Psicofisiológicos/classificação , Adolescente , Adulto , Fatores Etários , Feminino , Humanos , Histeria/etiologia , Histeria/psicologia , Acontecimentos que Mudam a Vida , Pessoa de Meia-Idade , Transtornos Psicofisiológicos/etiologia , Classe SocialRESUMO
The use of the drug grandaxin (made in Hungary) has demonstrated its high activity in the treatment of psychopathological disturbances of neurotic origin. Its administration is preferable when vegetative and hyposthenic disturbances are prevalent in the neurosis clinical picture. At the same time it alleviates the intensity of phobic and senestho-hypochondriacal experiences, however, its administration as the sole means for eliminating these disturbances seems undesirable. Neither can grandaxin be the drug of choice in controlling anxious and agrypnic disturbances. Psychogenic somatic syndromes have also appeared to be insensitive to the treatment with this drug. The side-effects produced by grandaxin are mild. The most persistent are nausea and headaches which develop in patients receiving high doses and subside in most cases spontaneously on reduction of the latter. No complications were noted.
Assuntos
Ansiolíticos/uso terapêutico , Benzodiazepinas/uso terapêutico , Transtornos Neuróticos/tratamento farmacológico , Adulto , Ansiolíticos/administração & dosagem , Ansiolíticos/efeitos adversos , Benzodiazepinas/administração & dosagem , Benzodiazepinas/efeitos adversos , Transtorno Depressivo/tratamento farmacológico , Feminino , Humanos , Hipocondríase/tratamento farmacológico , Neurastenia/tratamento farmacológico , Transtorno Obsessivo-Compulsivo/tratamento farmacológicoRESUMO
Under examination there were 173 patients with borderline neuropsychic disorders of the neurotic and neurosis-like genesis. In the course of the treatment the levels of acetylcholine and catecholamines were determined. It has been shown that in borderline neuropsychic disorders there are statistically significant differences in the levels of those neuromediators, these differences being characteristic for the neurotic and neurosis-like disorders. The process of the normalization of those levels was found to depend on the initial changes, which, in their turn, depended on the etiopathogenesis of the borderline disorders.